Structure of the human histamine H1 receptor complex with doxepin

Schwartz, J. C., Arrang, J. M., Garbarg, M., Pollard, H. & Ruat, M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 71, 1–51 (1991)

Hill, S. J. Distribution, properties, and functional characteristics of three classes of histamine receptor. Pharmacol. Rev. 42, 45–83 (1990)

Hill, S. J. et al. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49, 253–278 (1997)

Yamashita, M. et al. Expression cloning of a cDNA encoding the bovine histamine H1 receptor. Proc. Natl Acad. Sci. USA 88, 11515–11519 (1991)

Simons, F. E. Advances in H1-antihistamines. N. Engl. J. Med. 351, 2203–2217 (2004)

Overington, J. P., Al-Lazikani, B. & Hopkins, A. L. How many drug targets are there? Nature Rev. Drug Discov. 5, 993–996 (2006)

Bakker, R. A., Wieland, K., Timmerman, H. & Leurs, R. Constitutive activity of the histamine H1 receptor reveals inverse agonism of histamine H1 receptor antagonists. Eur. J. Pharmacol. 387, R5–R7 (2000)

Bakker, R. A., Schoonus, S. B., Smit, M. J., Timmerman, H. & Leurs, R. Histamine H1-receptor activation of nuclear factor-κB: roles for Gβγ- and Gαq/11-subunits in constitutive and agonist-mediated signaling. Mol. Pharmacol. 60, 1133–1142 (2001)

Tashiro, M. et al. Dose dependency of brain histamine H1 receptor occupancy following oral administration of cetirizine hydrochloride measured using PET with [11C]doxepin. Hum. Psychopharmacol. 24, 540–548 (2009)

Woosley, R. L., Chen, Y., Freiman, J. P. & Gillis, R. A. Mechanism of the cardiotoxic actions of terfenadine. J. Am. Med. Assoc. 269, 1532–1536 (1993)

Yap, Y. G. & Camm, A. J. Potential cardiac toxicity of H1-antihistamines. Clin. Allergy Immunol. 17, 389–419 (2002)

Okamura, N. et al. Functional neuroimaging of cognition impaired by a classical antihistamine, d-chlorpheniramine. Br. J. Pharmacol. 129, 115–123 (2000)

Cusack, B., Nelson, A. & Richelson, E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacology (Berl.) 114, 559–565 (1994)

Sarker, S. et al. The high-affinity binding site for tricyclic antidepressants resides in the outer vestibule of the serotonin transporter. Mol. Pharmacol. 78, 1026–1035 (2010)

Klabunde, T. & Hessler, G. Drug design strategies for targeting G-protein-coupled receptors. ChemBioChem 3, 928–944 (2002)

de Graaf, C., Rognan, D. & Customizing, G. Protein-coupled receptor models for structure-based virtual screening. Curr. Pharm. Des. 15, 4026–4048 (2009)

Palczewski, K. et al. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739–745 (2000)

Cherezov, V. et al. High-resolution crystal structure of an engineered human β2-adrenergic G protein-coupled receptor. Science 318, 1258–1265 (2007)

Warne, T. et al. Structure of a β1-adrenergic G-protein-coupled receptor. Nature 454, 486–491 (2008)

Jaakola, V. P. et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322, 1211–1217 (2008)

Murakami, M. & Kouyama, T. Crystal structure of squid rhodopsin. Nature 453, 363–367 (2008)

Wu, B. et al. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330, 1066–1071 (2010)

Chien, E. Y. et al. Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist. Science 330, 1091–1095 (2010)

Kolb, P. et al. Structure-based discovery of β2-adrenergic receptor ligands. Proc. Natl Acad. Sci. USA 106, 6843–6848 (2009)

Katritch, V. et al. Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists. J. Med. Chem. 53, 1799–1809 (2010)

Rosenbaum, D. M. et al. GPCR engineering yields high-resolution structural insights into β2-adrenergic receptor function. Science 318, 1266–1273 (2007)

Ratnala, V. R. et al. Large-scale overproduction, functional purification and ligand affinities of the His-tagged human histamine H1 receptor. Eur. J. Biochem. 271, 2636–2646 (2004)

Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure–function relations in G protein-coupled receptors. Methods Neurosci. 25, 366–428 (1995)

Qanbar, R. & Bouvier, M. Role of palmitoylation/depalmitoylation reactions in G-protein-coupled receptor function. Pharmacol. Ther. 97, 1–33 (2003)

Wieland, K. et al. Mutational analysis of the antagonist-binding site of the histamine H1 receptor. J. Biol. Chem. 274, 29994–30000 (1999)

Ohta, K. et al. Site-directed mutagenesis of the histamine H1 receptor: roles of aspartic acid107, asparagine198 and threonine194 . Biochem. Biophys. Res. Commun. 203, 1096–1101 (1994)

Nonaka, H. et al. Unique binding pocket for KW-4679 in the histamine H1 receptor. Eur. J. Pharmacol. 345, 111–117 (1998)

Bruysters, M. et al. Mutational analysis of the histamine H1-receptor binding pocket of histaprodifens. Eur. J. Pharmacol. 487, 55–63 (2004)

Peeters, M. C., van Westen, G. J., Li, Q. & Ijzerman, A. P. Importance of the extracellular loops in G protein-coupled receptors for ligand recognition and receptor activation. Trends Pharmacol. Sci. 32, 35–42 (2011)

Gillard, M. et al. H1 antagonists: receptor affinity versus selectivity. Inflamm. Res. 52 (Suppl. 1). S49–S50 (2003)

Kiss, R., Kovari, Z. & Keseru, G. M. Homology modelling and binding site mapping of the human histamine H1 receptor. Eur. J. Med. Chem. 39, 959–967 (2004)

Jongejan, A. & Leurs, R. Delineation of receptor–ligand interactions at the human histamine H1 receptor by a combined approach of site-directed mutagenesis and computational techniques—or—how to bind the H1 receptor. Arch. Pharm. (Weinheim) 338, 248–259 (2005)

Totrov, M. & Abagyan, R. Flexible protein–ligand docking by global energy optimization in internal coordinates. Proteins (Suppl. 1). 29, 215–220 (1997)

Katritch, V. et al. Analysis of full and partial agonists binding to β2-adrenergic receptor suggests a role of transmembrane helix V in agonist-specific conformational changes. J. Mol. Recognit. 22, 307–318 (2009)

Katritch, V., Kufareva, I. & Abagyan, R. Structure based prediction of subtype-selectivity for adenosine receptor antagonists. Neuropharmacology 60, 108–115 (2011)

Matsumoto, Y., Funahashi, J., Mori, K., Hayashi, K. & Yano, H. The noncompetitive antagonism of histamine H1 receptors expressed in Chinese hamster ovary cells by olopatadine hydrochloride: its potency and molecular mechanism. Pharmacology 81, 266–274 (2008)

Gillard, M., Van Der Perren, C., Moguilevsky, N., Massingham, R. & Chatelain, P. Binding characteristics of cetirizine and levocetirizine to human H1 histamine receptors: contribution of Lys191 and Thr194 . Mol. Pharmacol. 61, 391–399 (2002)

Leurs, R., Smit, M. J., Meeder, R., Ter Laak, A. M. & Timmerman, H. Lysine200 located in the fifth transmembrane domain of the histamine H1 receptor interacts with histamine but not with all H1 agonists. Biochem. Biophys. Res. Commun. 214, 110–117 (1995)

Bakker, R. A. et al. 8R-lisuride is a potent stereospecific histamine H1-receptor partial agonist. Mol. Pharmacol. 65, 538–549 (2004)

Xu, F. et al. Structure of an agonist-bound human A2A adenosine receptor. Science 332, 322–327 (2011)

Rasmussen, S. G. et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor. Nature 469, 175–180 (2011)

Newstead, S., Kim, H., von Heijne, G., Iwata, S. & Drew, D. High-throughput fluorescent-based optimization of eukaryotic membrane protein overexpression and purification in Saccharomyces cerevisiae . Proc. Natl Acad. Sci. USA 104, 13936–13941 (2007)

Cherezov, V., Peddi, A., Muthusubramaniam, L., Zheng, Y. F. & Caffrey, M. A robotic system for crystallizing membrane and soluble proteins in lipidic mesophases. Acta Crystallogr. D 60, 1795–1807 (2004)

Aishima, J. et al. High-speed crystal detection and characterization using a fast-readout detector. Acta Crystallogr. D 66, 1032–1035 (2010)

Winter, G. xia2: an expert system for macromolecular crystallography data reduction. J. Appl. Cryst. 43, 186–190 (2010)

Leslie, A. G. W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 ESF-EACMB Newslet. Protein Crystallogr. No. 26. (1992)

Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D 62, 72–82 (2006)

McCoy, A. J. et al. Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 (2007)

Skubák, P., Murshudov, G. N. & Pannu, N. S. Direct incorporation of experimental phase information in model refinement. Acta Crystallogr. D 60, 2196–2201 (2004)

Murshudov, G. N., Vagin, A. A. & Dodson, E. J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D 53, 240–255 (1997)

Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and Development of Coot. Acta Crystallogr. D 66, 486–501 (2010)

Abagyan, R., Orry, A., Raush, E. & Totrov, M. ICM Manual v.3.0 (MolSoft LLC, 2011)

Totrov, M. & Abagyan, R. Derivation of sensitive discrimination potential for virtual ligand screening. Proceedings of the third annual international conference on computational molecular biology 312–317. (1999)

Abagyan, R. & Totrov, M. Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. J. Mol. Biol. 235, 983–1002 (1994)